FDA will review Moderna’s data on vaccine for young kids without waiting for Pfizer
(WASHINGTON) -- The head of the Food and Drug Administration on Thursday said the agency would move along to review Moderna’s data for its kid vaccine regardless of when Pfizer submits its data on kids under five, a move that will be welcome news... Read More.